Advanced Nutriceuticals Recalls GHRP Vials Due to Sterility Concerns
Advanced Nutriceuticals is recalling GHRP vials because production processes cannot assure sterility. The product was distributed in seven states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the hazard involves a lack of assurance of sterility for a sterile product, which poses a significant risk of infection or serious injury.
Plain-English summary
Advanced Nutriceuticals, LLC is recalling GHRP, 2000 MCG/ML, 5 ML vials manufactured by The Guyer Institute of Molecular Medicine in Indianapolis, IN. The recall is due to concerns with production processes that cannot assure the sterility of products intended to be sterile.
The affected product is identified by Lot #1112202008 with an expiration date of 12/11/2020. The product was distributed in California, Colorado, Florida, Indiana, Kentucky, Ohio, and Texas.
Consumers who have this product should stop using it and contact Advanced Nutriceuticals, LLC for further instructions.
The recalled product
- Product
- GHRP, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
- Manufacturer
- Advanced Nutriceuticals, LLC
- Category
- Drug — Injectable
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #1112202008
- Exp 12/11/2020
Distribution
Part of a larger recall action
This product is one of 17 recalled by Advanced Nutriceuticals, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 17 products in this recall →Related recalls
Same manufacturer · Advanced Nutriceuticals, LLC
See all →- SeverePT-141 Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-12-23
- SevereFDA Recalls NANDROLONE Injections Due to Sterility Concerns
FDA (Drugs) · 2020-12-23
- SevereFDA Recalls Cerebrolysin Vials Due to Sterility Concerns
FDA (Drugs) · 2020-12-23
- SevereFDA Recalls Thymosin Beta-4 Vials Due to Sterility Concerns
FDA (Drugs) · 2020-12-23
- SevereFDA Recalls CJC-1295 Vials Due to Sterility Concerns
FDA (Drugs) · 2020-12-23
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereAdvanced Compounding Pharmacy Recalls Injectable Glutathione Due to Sterility Concerns
FDA (Drugs) · 2015-06-03
- SevereAdvanced Pharma Recalls Glycopyrrolate Injectable Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-03-27
- HighAdvanced Pharma Recalls Glycopyrrolate Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-03-27
- Severe
- ModerateAdvanced Pharma Recalls NitroGlycerin Syringes Due to Stability Data Issues
FDA (Drugs) · 2017-12-27
- SevereFDA Recalls HCG Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2015-09-23